top of page
Search
Rapport Therapeutics – RAP-219 Phase 2 Clinical Trial
Executive Summary Rapport has a phase 2 (P2) readout upcoming for RAP-219, a TARPy8 AMPA receptor modulator. The preclinical results are...
Aug 276 min read
Inmune Bio – XPro for Alzheimer’s Disease Phase 2
This article details why XPro and Inmune Bio will fail their Alzheimer's Phase 3 results.
May 177 min read
Cybin CYB004 (DMT) GAD Phase 2 Trial
This article discussses Cybin and their upcoming readout in Genearalized Anxiety Disorder.
Apr 223 min read
bottom of page